Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented,“The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...
NK cell therapy is gaining momentum as a promising solution to unmet medical needs in cancer treatment, offering safer, tar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback